Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James M. Falko

TitleProfessor-Clinical
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone720/848-1798

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Matney K, Berg M, Falko JM, Draper NL. The role of lipoprotein(a) in clotting reactions during lipoprotein apheresis--A case report. J Clin Lipidol. 2016 Mar-Apr; 10(2):438-42. PMID: 27055976.
      View in: PubMed
    2. Allian-Sauer MU, Falko JM. New treatments on the horizon for familial hypercholesterolemia. Expert Rev Cardiovasc Ther. 2012 Oct; 10(10):1227-37. PMID: 23190063.
      View in: PubMed
    3. Snow R, Ruane J, LaLonde M, Shaffer L, Kim B, Graffagnino C, Falko J, Spencer K, Caulin-Glaser T. Randomized trial assessing the impact of a musculoskeletal intervention for pain before participating in a weight management program. J Cardiopulm Rehabil Prev. 2010 May-Jun; 30(3):173-80. PMID: 20040884.
      View in: PubMed
    4. Kolluri R, Pinedo D, Edmondson-Holt A, Grewal KS, Falko JM. Dyslipidemia in South Asians living in a western community. J Clin Lipidol. 2009 Feb; 3(1):14-8. PMID: 21291784.
      View in: PubMed
    5. Brown WV, Clark L, Falko JM, Guyton JR, Rees TJ, Schonfeld G, Lopes-Virella MF. Optimal management of lipids in diabetes and metabolic syndrome. J Clin Lipidol. 2008 Oct; 2(5):335-42. PMID: 21291758.
      View in: PubMed
    6. La Londe MA, Graffagnino CL, Falko JM, Snow RJ, Spencer K, Caulin-Glaser T. Effect of a weight management program on the determinants and prevalence of metabolic syndrome. Obesity (Silver Spring). 2008 Mar; 16(3):637-42. PMID: 18239562.
      View in: PubMed
    7. Meis SB, Snow R, Lalonde M, Falko J, Caulin-Glaser T. A systematic approach to improve lipids in coronary artery disease patients participating in a cardiac rehabilitation program. J Cardiopulm Rehabil. 2006 Nov-Dec; 26(6):355-60; quiz 361-2. PMID: 17135854.
      View in: PubMed
    8. Graffagnino CL, Falko JM, La Londe M, Schaumburg J, Hyek MF, Shaffer LE, Snow R, Caulin-Glaser T. Effect of a community-based weight management program on weight loss and cardiovascular disease risk factors. Obesity (Silver Spring). 2006 Feb; 14(2):280-8. PMID: 16571854.
      View in: PubMed
    9. Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R. Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil. 2005 Nov-Dec; 25(6):332-6; quiz 337-8. PMID: 16327525.
      View in: PubMed
    10. Hindman L, Falko JM, LaLonde M, Snow R, Caulin-Glaser T. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation. Am Heart J. 2005 Nov; 150(5):1046-51. PMID: 16290994.
      View in: PubMed
    11. Snow R, LaLonde M, Hindman L, Falko J, Caulin-Glaser T. Independent effect of cardiac rehabilitation on lipids in coronary artery disease. J Cardiopulm Rehabil. 2005 Sep-Oct; 25(5):257-61; quiz 262-3. PMID: 16217226.
      View in: PubMed
    12. Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician. 2005 Jun 01; 71(11):2123-8. PMID: 15952441.
      View in: PubMed
    13. Aring AM, Jones DE, Falko JM. Information from your family doctor. Diabetic neuropathy. Am Fam Physician. 2005 Jun 01; 71(11):2129-30. PMID: 15952442.
      View in: PubMed
    14. Falko JM, Moser RJ, Meis SB, Caulin-Glaser T. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia. Curr Diabetes Rev. 2005 May; 1(2):127-35. PMID: 18220588.
      View in: PubMed
    15. Barker BJ, Goodenough RR, Falko JM. Fenofibrate monotherapy induced rhabdomyolysis. Diabetes Care. 2003 Aug; 26(8):2482-3. PMID: 12882895.
      View in: PubMed
    16. Cottrell DA, Marshall BJ, Falko JM. Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome. Curr Opin Cardiol. 2003 Jul; 18(4):301-8. PMID: 12858129.
      View in: PubMed
    17. Stoney CM, West SG, Hughes JW, Lentino LM, Finney ML, Falko J, Bausserman L. Acute psychological stress reduces plasma triglyceride clearance. Psychophysiology. 2002 Jan; 39(1):80-5. PMID: 12206298.
      View in: PubMed
    18. Sundaram V, Schuster DP, Falko JM. Unusual manifestations of cushing's syndrome in a multiple endocrine neoplasia type I kindred. Endocr Pract. 1998 Jul-Aug; 4(4):190-4. PMID: 15251731.
      View in: PubMed
    19. Cirillo RL, Pozderac RV, Caniano DA, Falko JM. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule. Clin Nucl Med. 1998 Jun; 23(6):345-9. PMID: 9619317.
      View in: PubMed
    20. Sundaram V, Hanna AN, Lubow GP, Koneru L, Falko JM, Sharma HM. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci. 1997 Nov; 314(5):303-10. PMID: 9365332.
      View in: PubMed
    21. Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab. 1997 Oct; 82(10):3421-4. PMID: 9329379.
      View in: PubMed
    22. Jhiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM, Mazzaferri EL. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid. 1996 Apr; 6(2):115-21. PMID: 8733882.
      View in: PubMed
    23. Glueck CJ, Streicher P, Wang P, Sprecher D, Falko JM. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition. 1996 Mar; 12(3):202-5. PMID: 8798226.
      View in: PubMed
    24. Olmos PR, Falko JM, Rea GL, Boesel CP, Chakeres DW, McGhee DB. Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies. Neurosurgery. 1993 Jun; 32(6):1015-21; discussion 1021. PMID: 8327075.
      View in: PubMed
    25. Bello F, Falko JM, O'Dorisio TM, Osei K. The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients. Diabet Med. 1991 May; 8(4):385-7. PMID: 1830262.
      View in: PubMed
    26. Cottrell DA, Bello FA, Falko JM. 17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism. Am J Med Sci. 1990 Dec; 300(6):380-2. PMID: 2264576.
      View in: PubMed
    27. Chevinsky AH, Minton JP, Falko JM. Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg. 1990 Jul; 125(7):935-8. PMID: 1695090.
      View in: PubMed
    28. Falko JM, Parr JH, Simpson RN, Wynn V. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med. 1987 Oct; 83(4):641-7. PMID: 3674053.
      View in: PubMed
    29. Osei K, Falko J, Bossetti BM, Holland GC. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med. 1987 Aug; 83(2):249-55. PMID: 3618627.
      View in: PubMed
    30. Trapnell BC, Mavko LE, Birskovich LM, Falko JM. Metoclopramide suppositories in the treatment of diabetic gastroparesis. Arch Intern Med. 1986 Nov; 146(11):2278-9. PMID: 3778059.
      View in: PubMed
    31. Osei K, Holland G, Falko JM. Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med. 1986 Oct; 146(10):1973-7. PMID: 3767542.
      View in: PubMed
    32. Osei K, Weber PA, Falko JM. Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol. 1986 May; 18(5):196-8. PMID: 3717843.
      View in: PubMed
    33. Osei K, Falko JM. Chronic hyponatremia associated with diabetic amyotrophy. Arch Intern Med. 1986 Mar; 146(3):534-6. PMID: 3082305.
      View in: PubMed
    34. Feher MD, Falko JM. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J (Clin Res Ed). 1986 Mar 01; 292(6520):623. PMID: 3081197; PMCID: PMC1339600.
    35. Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab. 1986 Feb; 62(2):325-30. PMID: 3510224.
      View in: PubMed
    36. Osei K, Falko JM, Fields PG, Bossetti B, O'Dorisio TM. The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia. 1986 Feb; 29(2):100-5. PMID: 3516764.
      View in: PubMed
    37. Pariser SF, Stern SL, Shank ML, Falko JM, O'Shaughnessy RW, Friedman CI. Premenstrual syndrome: concerns, controversies, and treatment. Am J Obstet Gynecol. 1985 Nov 15; 153(6):599-604. PMID: 3933354.
      View in: PubMed
    38. Abdel-Nabi H, Hinkle GH, Falko JM, Kelly D, Olsen JO, Martin EW. Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma. Clin Nucl Med. 1985 Oct; 10(10):713-5. PMID: 4075656.
      View in: PubMed
    39. Falko JM, Osei K. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med. 1985 Sep 20; 79(3B):92-101. PMID: 3931467.
      View in: PubMed
    40. Osei K, Falko JM, O'Dorisio TM, Adam DR. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care. 1985 Sep-Oct; 8(5):436-9. PMID: 3902421.
      View in: PubMed
    41. Osei K, Falko JM. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Am J Med Sci. 1985 Apr; 289(4):148-53. PMID: 3920907.
      View in: PubMed
    42. Rudy DR, Falko JM. Osteoporosis in primary care. Ohio State Med J. 1985 Mar; 81(3):208-12. PMID: 3982779.
      View in: PubMed
    43. Osei K, O'Dorisio TM, Falko JM. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med. 1984 Dec; 77(6):1002-9. PMID: 6439036.
      View in: PubMed
    44. Osei K, Falko JM. Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J. 1984 Dec; 80(12):864-9. PMID: 6098886.
      View in: PubMed
    45. Osei K, Kramer DS, Malarkey WB, Falko JM. Pregnancy complicated by insulinoma. Am J Med Sci. 1984 Oct; 288(3):133-5. PMID: 6091457.
      View in: PubMed
    46. Patel ST, Newman HA, Yates AJ, Thibert P, Falko JM. Serum lipids and lipoprotein composition in spontaneously diabetic BB Wistar rats. J Lipid Res. 1984 Oct; 25(10):1072-83. PMID: 6512413.
      View in: PubMed
    47. Osei K, Falko JM, O'Dorisio TM, Adam DR, Cataland S. Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients. Diabetes Care. 1984 Sep-Oct; 7(5):442-6. PMID: 6389058.
      View in: PubMed
    48. Abdel-Nabi H, Falko JM, Olsen JO, Freimanis AK. Solitary cold thyroid nodule: cost-ineffectiveness of ultrasonography. South Med J. 1984 Sep; 77(9):1146-8. PMID: 6435260.
      View in: PubMed
    49. Osei K, Falko JM, O'Dorisio TM, Adam DR. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care. 1984 Sep-Oct; 7(5):471-5. PMID: 6389061.
      View in: PubMed
    50. Osei K, Falko JM, Nelson KP, Stephens R. Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med. 1984 Jul; 77(1):41-6. PMID: 6331162.
      View in: PubMed
    51. Bossetti BM, Kocher LM, Moranz JF, Falko JM. The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care. 1984 Jul-Aug; 7(4):309-12. PMID: 6381003.
      View in: PubMed
    52. Falko JM, Maeder MC, Conway C, Mazzaferri EL, Skillman TG. Primary hyperparathyroidism: analysis of 220 patients with special emphasis on familial hypocalciuric hypercalcemia. Heart Lung. 1984 Mar; 13(2):124-31. PMID: 6559790.
      View in: PubMed
    53. Levin P, Falko JM, O'Dorisio TM, Cataland S. Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabetics. Am J Med Sci. 1983 Nov-Dec; 286(3):11-7. PMID: 6356914.
      View in: PubMed
    54. Osei K, Falko JM, Pacht E, Wall R, Goldberg RF. Primary adrenal insufficiency manifesting as malignant lymphoma. Arch Intern Med. 1983 Sep; 143(9):1791-2. PMID: 6615102.
      View in: PubMed
    55. Pizzino J, Falko JM, Moses JL. Ocular changes in Graves' disease. Ohio State Med J. 1983 Aug; 79(8):627-9. PMID: 6353306.
      View in: PubMed
    56. Bissinger C, Falko JM, Maher W, Rarick M, Cerilli J, Johnson J. Hypertensive crisis induced by eating in a patient with pheochromocytoma. J Clin Gastroenterol. 1983 Apr; 5(2):155-7. PMID: 6853988.
      View in: PubMed
    57. Hill SA, Falko JM, Wilson CB, Hunt WE. Thyrotrophin-producing pituitary adenomas. J Neurosurg. 1982 Oct; 57(4):515-9. PMID: 6809907.
      View in: PubMed
    58. Friedman CI, Falko JM, Patel ST, Kim MH, Newman HA, Barrows H. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females. J Clin Endocrinol Metab. 1982 Aug; 55(2):258-62. PMID: 7085852.
      View in: PubMed
    59. Falko JM, Reynolds JC, O'Dorisio TM, Bossetti B, Cataland S. The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose. Diabetes Care. 1982 Jul-Aug; 5(4):379-85. PMID: 6759077.
      View in: PubMed
    60. Falko JM, O'Dorisio TM, Cataland S. Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia. Arch Intern Med. 1982 Jul; 142(7):1370-1. PMID: 7092450.
      View in: PubMed
    61. Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. J Clin Endocrinol Metab. 1982 Jun; 54(6):1210-5. PMID: 7076797.
      View in: PubMed
    62. Hawley PC, Falko JM. "Pseudo" renal failure after isopropyl alcohol intoxication. South Med J. 1982 May; 75(5):630-1. PMID: 7079831.
      View in: PubMed
    63. O'Dorisio TM, Falko JM, Cataland S, Almoney RW, George JM, Mazzaferri EL, Reynolds JC. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma. J Clin Endocrinol Metab. 1982 Apr; 54(4):798-802. PMID: 7061688.
      View in: PubMed
    64. Abdel-Nabi H, Falko JM, Olsen J. The value of technetium Tc 99m pertechnetate thyroid scanning in the diagnosis of factitious thyrotoxicosis. Arch Intern Med. 1982 Mar; 142(3):644-5. PMID: 7065802.
      View in: PubMed
    65. Schear EA, Falko JM, Cataland S, Johnson J, Fanning W. Diabetes insipidus and breast cancer. South Med J. 1982 Mar; 75(3):354-6. PMID: 7063912.
      View in: PubMed
    66. Doherty DE, Falko JM, Lefkovitz N, Rogers J, Fromkes J. Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci. 1982 Feb; 27(2):169-70. PMID: 7075412.
      View in: PubMed
    67. Falko JM, O'Dorisio TM, Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 01; 247(1):37-9. PMID: 7031287.
      View in: PubMed
    68. Abdel-Nabi H, Scheu J, Ragosin R, Falko JM, Olsen J. Thyroid uptake of Tc-99m compromising in vivo RBC tagging. J Nucl Med. 1981 Nov; 22(11):1018-9. PMID: 6271937.
      View in: PubMed
    69. Yovos JG, Falko JM, O'Dorisio TM, Malarkey WB, Cataland S, Capen CC. Thyrotoxicosis and a thyrotropin-secreting pituitary tumor causing unilateral exophthalmos. J Clin Endocrinol Metab. 1981 Aug; 53(2):338-43. PMID: 6788793.
      View in: PubMed
    70. Pariser SF, Reynolds JC, Falko JM, Jones BA, Mencer DL. Arrhythmia induced by a tricyclic antidepressant in a patient with undiagnosed mitral valve prolapse. Am J Psychiatry. 1981 Apr; 138(4):522-3. PMID: 7212115.
      View in: PubMed
    71. Zull DN, Falko JM. Metrizamide cisternography in the investigation of the empty sella syndrome. Arch Intern Med. 1981 Mar; 141(4):487-9. PMID: 7212891.
      View in: PubMed
    72. Skillman TG, Falko JM. Recognizing thyroid disease in the elderly: current considerations. Geriatrics. 1981 Jan; 36(1):63-73. PMID: 7450505.
      View in: PubMed
    73. Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Clin Endocrinol (Oxf). 1980 Dec; 13(6):587-93. PMID: 7014042.
      View in: PubMed
    74. Levin PA, Falko JM, Dixon K, Gallup EM, Saunders W. Benign parotid enlargement in bulimia. Ann Intern Med. 1980 Dec; 93(6):827-9. PMID: 6160796.
      View in: PubMed
    75. Falko JM. High density lipoprotein (HDL): a protective lipoprotein. Ohio State Med J. 1980 Aug; 76(8):513-5. PMID: 7402518.
      View in: PubMed
    76. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism. 1980 Jul; 29(7):654-61. PMID: 7382829.
      View in: PubMed
    77. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Weidman SW, Steelman R. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab. 1980 Mar; 50(3):521-8. PMID: 7358833.
      View in: PubMed
    78. Falko JM, Schonfeld G, Witztum JL, Kolar J, Weidman SW. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism. 1979 Nov; 28(11):1171-7. PMID: 226834.
      View in: PubMed
    79. Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med. 1979 Nov; 91(5):750-1. PMID: 227301.
      View in: PubMed
    80. Falko JM, Williams JC, Harvey DG, Weidman SW, Schonfeld G, Dodson WE. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr. 1979 Oct; 95(4):523-9. PMID: 480026.
      View in: PubMed
    81. Weidman SW, Suarez B, Falko JM, Witztum JL, Kolar J, Raben M, Schonfeld G. Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med. 1979 Apr; 93(4):549-69. PMID: 219120.
      View in: PubMed
    82. Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med. 1979 Feb; 66(2):303-10. PMID: 218451.
      View in: PubMed
    83. Thomas FB, Sinar D, Caldwell JH, Mekhjian HS, Falko JM. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology. 1977 Aug; 73(2):221-5. PMID: 873120.
      View in: PubMed
    84. Falko JM. Hazards in antihypertension therapy. Ann Intern Med. 1977 Jan; 86(1):111-2. PMID: 835911.
      View in: PubMed
    85. Thomas FB, Falko JM, Zuckerman K. Inhibition of intestinal iron absorption by laundry starch. Gastroenterology. 1976 Dec; 71(6):1028-32. PMID: 11141.
      View in: PubMed
    86. Falko JM, Berenzweig HK. Letter: Thyrotoxic hypercalcemia, renal tubular acidosis, and pancreatitis. Ann Intern Med. 1976 Sep; 85(3):404. PMID: 962237.
      View in: PubMed
    87. Falko JM, Guy JT, Smith RE, Mazzaferri EL. Primary hyperparathyroidism and anemia. Arch Intern Med. 1976 Aug; 136(8):887-9. PMID: 949188.
      View in: PubMed
    88. Crockett SE, Cataland S, Falko JM, Mazzaferri EL. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab. 1976 Jun; 42(6):1098-103. PMID: 932174.
      View in: PubMed
    89. Falko JM, Cohen JR. Letter: Erythrocytosis and hypothyroidism. Ann Intern Med. 1976 Apr; 84(4):446-7. PMID: 1259289.
      View in: PubMed
    90. Falko JM, Bush CA, Tzagournis M, Thomas FB. Case report. Congestive heart failure complicating the hungry bone syndrome. Am J Med Sci. 1976 Jan-Feb; 271(1):85-9. PMID: 130801.
      View in: PubMed
    91. Falko JM, Thomas FB. Letter: Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med. 1975 Dec; 83(6):832-3. PMID: 1200531.
      View in: PubMed
    92. Falko JM, Crockett SE, Cataland S, Mazzaferri EL. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab. 1975 Aug; 41(2):260-5. PMID: 1159045.
      View in: PubMed
    93. Falko JM, Mekhjian HS, Thomas FB. Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstruction. Am J Dig Dis. 1975 Jun; 20(6):583-87. PMID: 1130380.
      View in: PubMed
    Falko's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)